Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
Bio-Rad Diabetes Division

Next Gen Sequencing Generates High Quality Data

By Labmedica International staff writers
Posted on 03 Jan 2012
A leader in clinical diagnostics and genomic services has officially launched its Next-Gen sequencing services.

Scientists have a wide range of sequencing read options ranging from 36 base pair (bp) singleton to 150 bp paired-end reads. The system is capable of generating over 2 gigabyte (GB) data per run with a high percentage of bases over Q30.

The high data yield and superior quality allows scientists to conduct a wide variety of sequencing applications including: highly multiplexed polymerase chain reaction (PCR) amplicon sequencing, small genome sequencing and de novo sequencing, small RNA sequencing, targeted resequencing, and 16S metagenomics.

Ambry Genetics (Aliso Viejo, CA, USA) has officially launched their Next-Gen sequencing services Illumina MiSeq. Ambry Genetics has been an adapter of Illumina (San Diego, CA, USA) sequencing systems for several years and has extensive experience as a Certified Service Provider processing thousands of samples. The Illumina MiSeq uses the same established reversible-terminator sequencing by synthesis chemistry as the HiSeq2000.

"The MiSeq is a fully integrated sequencing platform enabling up to 2 GB of sequencing data using Illumina's established and reliable TruSeq technology. The quick run time and high data yield make the system ideal for amplicon and targeted resequencing projects," said Dr. Aaron Elliott, Director of Genomic Services.

Ambry Genetics is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified commercial clinical laboratory. It has become a leader in providing genetic services focused on clinical diagnostics and genomic services, particularly sequencing and array services.

Related Links:
Ambry Genetics
Illumina



77 ELEKTRONIKA
DiagCor Bioscience
PURITAN MEDICAL
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image:  The Agilent 6890 GC with 5973 Mass Spectrometer and Tekmar Velocity XPT Purge & Trap (Photo courtesy of Gen Tech).

Low Levels of Prohormone Predicts Coronary Heart Disease

The adrenal sex hormone dehydroepiandrosterone (DHEA), which is present in serum mainly as the sulfate DHEA-S, is the most abundant steroid hormone in human blood and its levels decline dramatically with age.... Read more

Microbiology

view channel
Image: The causative parasite of Chagas disease Trypanosoma cruzi in a blood film (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).

Undiagnosed Chagas Disease Emerging as Public Health Threat

Chagas disease or American trypanosomiasis is typically spread to people through the feces of blood-sucking triatomine bugs sometimes called kissing bugs because they feed on people's faces during the night.... Read more

Pathology

view channel

Identification of Independent Primary Lung Tumors and Tumors with Metastases Using Next-Generation DNA Sequencing

A team of oncologists and surgeons used a next-generation DNA sequencing (NGS) technique to determine whether non-small-cell lung cancer patients with multiple tumors carried independent primary tumors or a single primary tumor that had metastasized. For patients with multiple tumors, distinguishing independent primary... Read more

Industry News

view channel

Oncology Companion Diagnostics Sector Grows to Over USD 1 Billion

The market for diagnostic test and pharmaceutical drug pairs for cancer treatment has grown significantly, according to the report “Companion Diagnostic Markets” from healthcare market research firm Kalorama Information (New York City, NY, USA). The global companion diagnostics (CDx) market is valued at about USD 1.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.